The Effects of High-dose Dual Therapy With Probiotics on Gut Microbiota for Helicobacter Pylori Rescue Treatment
Key facts
- Who runs it
- Zhongshan Hospital (Xiamen), Fudan University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 72 people enrolled
- Started
- 31 Jan 2024
- Ended
- 28 Feb 2025
- Type of study
- Interventional, 4 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Vonoprazan
- Amoxicillin
- Bacillus subtilis enteric-coated capsules
- Record updated
- 13 May 2025
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (9)Hide the full registry criteria
Who can take part
- Age from 18 to 65 years
- H.pylori infection diagnosed by 13C-urea breath test
- A period of more than two months since the last eradication therapy for H. pylori
- Patients who had previously failed 2 or more eradication regimens
Who cannot take part
- Coexistence of significant concomitant illnesses, including heart disease, renal failure, hepatic disease, previous abdominal surgery, lactation, or pregnancy
- Allergy to any of the medications
- Zollinger-Ellison syndrome, GC, Upper gastrointestinal bleeding, or Active peptic ulcer
- Patients who had used probiotics, vonoprazan, and antibiotics in the past 12 weeks
- Unwillingness to participate in this study
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study was to evaluate the effects of High-dose Dual therapy combined with probiotics on the gut microbiota for Helicobacter pylori rescue treatment.
The 4 groups in the trial
- Group ATreatment being tested
vonoprazan 20 mg bid + amoxicillin 0.75 g qid for 14 days, followed by 2 doses of bacillus subtilis enteric-coated capsules for 14 days.
Treatment: Vonoprazan, Amoxicillin, and Bacillus subtilis enteric-coated capsules
- Group BTreatment being tested
vonoprazan 20 mg bid + amoxicillin 0.75 g qid+ 2 doses of bacillus subtilis enteric-coated capsules for 14 days.
Treatment: Vonoprazan, Amoxicillin, and Bacillus subtilis enteric-coated capsules
- Group CTreatment being tested
2 doses of bacillus subtilis enteric-coated capsules for 14 days, followed by vonoprazan 20 mg bid + amoxicillin 0.75 g qid for 14 days.
Treatment: Vonoprazan, Amoxicillin, and Bacillus subtilis enteric-coated capsules
- Group DExisting treatment, for comparison
vonoprazan 20 mg bid + amoxicillin 0.75 g qid for 14 days.
Treatment: Vonoprazan and Amoxicillin
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effects of High-dose Dual Therapy Combined With Probiotics on Gut Microbiota for Helicobacter Pylori Rescue Treatment: A Prospective, Multicenter, Randomized Trial
- Record updated
- 13 May 2025